Investors are increasingly eyeing the fast-growing MedSurg equipment space, which is projected to witness a compound annual growth rate (CAGR) of 9.54% from 2025 to 2030 (per Grand View Research). Two ...

The Boston Globe Its stock is up 50 percent. Billion-dollar deals for breakfast. How did Boston Scientific get its mojo back? “It’s been a brick by brick, constant improvement, strengthening ...

Boston Scientific developed a system: Set aside 10 percent of revenue for research and development, including to advance already acquired technologies, and devote much of its profits to new deals.

Boston Scientific stock is currently trading close to its 52-week high. In the past four trading sessions, the stock has consistently traded above $94.00 per share, closing at $95.65 yesterday.

Boston Scientific's earnings growth may slow to the low teens, making current P/E multiples hard to justify. See why BSX stock is a Hold.

For first-quarter 2025, Boston Scientific projects adjusted earnings in the range of 66-68 cents per share. Revenue growth is projected in the range of approximately 17-19% on a reported basis (up ...

Boston Scientific posted Q4 revenue of $4.56 billion, surpassing estimates. The company forecasts 2025 sales growth of up to 14.5% and EPS of $2.80-$2.87.

Medical-products company Boston Scientific reported third-quarter results before market open Last Updated: Oct. 23, 2024 at 7:39 a.m. ET First Published: Oct. 23, 2024 at 6:55 a.m. ET Share ...

Boston Scientific’s Relievant Medsystems used at least 80 unclaimed bodies for training, including that of a murdered 21-year-old woman whose family was fighting to bring her home. The company ...

Shares of Boston Scientific slipped 0.7% to $105.46 in early trading Wednesday, while shares of Edwards rose 1.8% to $77.60 and shares of Medtronic gained 1.1% to $82.06.

With the acquisition, Boston Scientific will pay $360 million upfront for the remaining 90% stake and up to an additional $180 million once specific regulatory milestones are met.